Arjumand, W., Ahmad, S. T., Nafees, S., Ali, N., Rashid, S., Seth, A., & Sultana, S. (2012). GNAS1 (Gαs) gene T393C polymorphism and renal cell carcinoma risk in a North Indian population: A case–control study. Genetic Testing and Molecular Biomarkers, 16(9), 1062–1066.

Bray, F., Colombet, M., Aitken, J. F., Bardot, A., Eser, S., Galceran, J., Hagenimana, M., Matsuda, T., Mery, L., Piñeros, M., Soerjomataram, I., de Vries, E., Wiggins, C., Won, Y. J., Znaor, A., & Ferlay, J. (Eds.). (2023). Cancer incidence in five continents. Vol. 12. In: IARC Cancer Base. No. 19. International Agency for Research on Cancer, Lyon.

Chen, J., & Iyengar, R. (1994). Suppression of Ras-induced transformation of NIH 3T3 cells by activated GαS. Science, 263(5151), 1278–1281.

DeGeorge, K. C., Holt, H. R., & Hodges, S. C. (2017). Bladder cancer: Diagnosis and treatment. American Family Physician, 96(8), 507–514.

Fadaka, A. O., Bakare, O. O., Pretorius, A., & Klein, A. (2020). Genomic profiling of microRNA target genes in colorectal cancer. Tumour Biology, 42(6), 1010428320933512.

Flaig, T. W., Spiess, P. E., Abern, M., Agarwal, N., Bangs, R., Buyyounouski, M. K., Chan, K., Chang, S. S., Chang, P., Friedlander, T., Greenberg, R. E., Guru, K. A., Herr, H. W., Hoffman-Censits, J., Kaimakliotis, H., Kishan, A. U., Kundu, S., Lele, S. M., Mamtani, R., Mian, O. Y., … Gurski, L. A. (2024). NCCN Guidelines® Insights: Bladder cancer. Version 3.2024. Journal of the National Comprehensive Cancer Network, 22(4), 216–225.

Frey, U. H., Eisenhardt, A., Lümmen, G., Rübben, H., Jöckel, K. H., Schmid, K. W., & Siffert, W. (2005). The T393C polymorphism of the G alpha s gene (GNAS1) is a novel prognostic marker in bladder cancer. Cancer Epidemiology, Biomarkers and Prevention, 14(4), 871–877.

Huetter, F. K., Bachmann, H. S., Reinders, A., Siffert, D., Stelmach, P., Knop, D., Horn, P. A., & Siffert, W. (2016). Association of a common oxytocin receptor gene polymorphism with self-reported 'empathic concern' in a large population of healthy volunteers. PloS One, 11(7), e0160059.

Myklebust, J. H., Josefsen, D., Blomhoff, H. K., Levy, F. O., Naderi, S., Reed, J. C., & Smeland, E. B. (1999). Activation of the cAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of Mcl-1 expression. Journal of Cellular Physiology, 180(1), 71–80.

Otterbach, F., Callies, R., Frey, U. H., Schmitz, K. J., Wreczycki, C., Kimmig, R., Siffert, W., & Schmid, K. W. (2007). The T393C polymorphism in the gene GNAS1 of G protein is associated with survival of patients with invasive breast carcinoma. Breast Cancer Research and Treatment, 105(3), 311–317.

Peeters, T., Louwet, W., Geladé, R., Nauwelaers, D., Thevelein, J. M., & Versele, M. (2006). Kelch-repeat proteins interacting with the Galpha protein Gpa2 bypass adenylate cyclase for direct regulation of protein kinase A in yeast. Proceedings of the National Academy of Sciences of the United States of America, 103(35), 13034–13039.

Peitz, T., Möhlendick, B., Eisenberger, U., Siffert, W., Heinemann, F. M., Kribben, A., & Friebus-Kardash, J. (2022). CC genotype of GNAS c.393C>T (rs7121) polymorphism has a protective effect against development of BK viremia and BKV-associated nephropathy after renal transplant. Pathogens, 11(10), 1138.

Sambrook, J., & Russell, D. W. (2001). Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory Press, New York.

Sandhu, S., Moore, C. M., Chiong, E., Beltran, H., Bristow, R. G., & Williams, S. G. (2021). Prostate cancer. Lancet, 398(10305), 1075–1090.

Sheskin, D. J. (2004). Handbook of parametric and nonparametric statistical procedures. CRC Press, Boca Raton.

Siegel, R. L., Giaquinto, A. N., & Jemal, A. (2024). Cancer statistics, 2024. CA: A Cancer Journal for Clinicians, 74(1), 12–49.

Steffen, D. J., Amornphimoltham, P., Valera, J. L. C., Taylor, S., Hunter, T., Tamayo, P., & Gutkind, J. S. (2017). GNAS-PKA oncosignaling network in colorectal cancer. The FASEB Journal, 31(S1), lb527.

Weinstein, L. S., Liu, J., Sakamoto, A., Xie, T., & Chen, M. (2004). Minireview: GNAS: Normal and abnormal functions. Endocrinology, 145(12), 5459–5464.

Wilson, C. H., McIntyre, R. E., Arends, M. J., & Adams, D. J. (2010). The activating mutation R201C in GNAS promotes intestinal tumourigenesis in ApcMin/+ mice through activation of Wnt and ERK1/2 MAPK pathways. Oncogene, 29(32), 4567–4575.

Yan, L., Herrmann, V., Hofer, J. K., & Insel, P. A. (2000). β-Adrenergic receptor/cAMP-mediated signaling and apoptosis of S49 lymphoma cells. American Journal of Physiology-Cell Physiology, 279(5), C1665–C1674.

Zauber, P., Marotta, S. P., & Sabbath-Solitare, M. (2016). GNAS gene mutation may be present only transiently during colorectal tumorigenesis. International Journal of Molecular Epidemiology and Genetics, 7(1), 24–31.